oxiracetam has been researched along with Encephalopathy, Traumatic in 2 studies
oxiracetam: structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The in vitro study used a cell injury controller to damage SH-SY5Y cells and evaluate the effect of oxiracetam at a dosage of 100 nM." | 1.91 | Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury. ( Cho, SM; Choi, H; Han, SW; Hong, EP; Jeon, JP; Jung, H; Kim, JT; Kim, N; Lee, A; Lee, Y; Park, CH; Youn, DH, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Youn, DH | 1 |
| Han, SW | 1 |
| Kim, JT | 1 |
| Choi, H | 1 |
| Lee, A | 1 |
| Kim, N | 1 |
| Jung, H | 1 |
| Hong, EP | 1 |
| Park, CH | 1 |
| Lee, Y | 1 |
| Cho, SM | 1 |
| Jeon, JP | 1 |
| Nozari, A | 1 |
| Sharma, A | 1 |
| Wang, Z | 1 |
| Feng, L | 1 |
| Muresanu, DF | 1 |
| Tian, ZR | 1 |
| Lafuente, JV | 1 |
| Buzoianu, AD | 1 |
| Wiklund, L | 1 |
| Sharma, HS | 1 |
1 review available for oxiracetam and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.
Topics: Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Brain; Brain Injuries, Traumatic; Hot Temper | 2023 |
1 other study available for oxiracetam and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Caspases; Cognitive Dysfunction; Cyclo | 2023 |